Charly Chahwan
Co-Founder & Chief Scientific Officer SyntheX
Seminars
Thursday 18th September 2025
Panel Discussion: Delving into Strategies to Achieve Selective Targeting of NRAS & HRAS Mutations for Successfully Treating a Wide Array of Cancers
2:00 pm
- Uncovering preclinical evidence to showcase the potential for NRAS and HRAS-targeting programs
- How to selectively target NRAS or HRAS and minimize off-target effects
- How to develop a successful patient stratification strategy for clinical trials related to NRASmutant and HRAS-mutant cancer
Tuesday 16th September 2025
Chair’s Opening Remarks
8:50 am
Tuesday 16th September 2025
Chair’s Closing Remarks & End of Focus Day
4:45 pm
